Pontoriero G, Locatelli F, Andreucci V E, Bragg-Gresham J, Eichleavy M A, Pisoni R L, Port F K
Divisione di Nefrologia e Dialisi, Ospedale A. Manzoni, Lecco - Italy.
G Ital Nefrol. 2007 May-Jun;24(3):221-9.
Knowing the relative risk (RR) of mortality associated with being outside the guideline targets and the percentage of patients in this situation, it is possible to estimate the number of patient life years that could be gained from adhering to guideline recommendations. We used a prevalent cross-sectional sample of 576 Italian patients from the Dialysis Outcomes and Practices Patterns Study (DOPPS) phase II (2002-2004) to determine the percentage of patients who failed to meet the Italian Society of Nephrology's targets for dialysis dose (spKt/V ≥ 1.3), anemia management (hemoglobin ≥ 11 g/dL), and mineral metabolism (serum calcium and phosphorus: ≤ 2.6 and ≤ 1.8 mmol/L, respectively), and the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (K/DOQI) targets for nutritional status (serum albumin ≥ 4 g/dL) and vascular access (facility catheter use ≤ 10%). We used a larger random sample of DOPPS patients to establish the adjusted RRs of mortality associated with the 6 examined targets. The percentage of patients outside the targets and the adjusted RRs were 34% and 1.12 for dialysis dose, 37.7% and 1.20 for anemia management, 40.8% and 1.14 for phosphorus, 14.4% and 1.22 for calcium, 62.5% and 1.46 for albumin, and 40.1% and 1.20 for facility catheter use. The adjusted sum of life years potentially gained by complete adherence to all 6 guidelines was 25,156 over a period of 5 years (2006-2010); a more conservative estimate, modeling life years potentially gained by bringing half of all patients outside targets within them, was 13,382. In conclusion, this analysis suggests opportunities to improve hemodialysis patient care in Italy. The magnitude of potential savings in life years should encourage greater adherence to guidelines and practices that are significantly associated with better survival.
了解与未达指南目标相关的死亡相对风险(RR)以及处于这种情况的患者百分比后,就有可能估算出因遵循指南建议而可获得的患者生命年数。我们使用了来自透析结果与实践模式研究(DOPPS)第二阶段(2002 - 2004年)的576名意大利患者的现患横断面样本,以确定未达到意大利肾脏病学会透析剂量目标(spKt/V≥1.3)、贫血管理目标(血红蛋白≥11 g/dL)和矿物质代谢目标(血清钙和磷分别≤2.6和≤1.8 mmol/L),以及美国国家肾脏基金会肾脏病预后质量倡议(K/DOQI)营养状况目标(血清白蛋白≥4 g/dL)和血管通路目标(中心静脉导管使用率≤10%)的患者百分比。我们使用了更大的DOPPS患者随机样本,以确定与6个检查目标相关的校正后死亡RR。未达目标的患者百分比以及校正后的RR分别为:透析剂量,34%和1.12;贫血管理,37.7%和1.20;磷,40.8%和1.14;钙,14.4%和1.22;白蛋白,62.5%和1.46;中心静脉导管使用,40.1%和1.20。完全遵循所有6项指南在5年期间(2006 - 2010年)潜在可获得的生命年校正总和为25,156;一个更保守的估计是,将所有未达目标患者的一半纳入目标范围后潜在可获得的生命年数为13,382。总之,该分析表明意大利在改善血液透析患者护理方面存在机会。生命年潜在节省的幅度应促使人们更严格地遵循与更好生存显著相关的指南和实践。